574 related articles for article (PubMed ID: 28910194)
1. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
Amdekar S; Parashar D; Alagarasu K
Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya Virus Evades Antiviral CD8
Davenport BJ; Bullock C; McCarthy MK; Hawman DW; Murphy KM; Kedl RM; Diamond MS; Morrison TE
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102875
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
[TBL] [Abstract][Full Text] [Related]
4. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.
Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF
J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257
[TBL] [Abstract][Full Text] [Related]
5. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
Fox JM; Diamond MS
J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
[TBL] [Abstract][Full Text] [Related]
6. Chikungunya virus pathogenesis and immunity.
Gasque P; Couderc T; Lecuit M; Roques P; Ng LF
Vector Borne Zoonotic Dis; 2015 Apr; 15(4):241-9. PubMed ID: 25897810
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms of chikungunya pathogenesis.
Lum FM; Ng LF
Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Novel Primary Human Skeletal Myoblast Cellular Model for Chikungunya Virus Infection and Pathogenesis.
Hussain KM; Lee RC; Ng MM; Chu JJ
Sci Rep; 2016 Feb; 6():21406. PubMed ID: 26892458
[TBL] [Abstract][Full Text] [Related]
9. Chikungunya virus: host pathogen interaction.
Singh SK; Unni SK
Rev Med Virol; 2011 Mar; 21(2):78-88. PubMed ID: 21412934
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus-vector interactions.
Coffey LL; Failloux AB; Weaver SC
Viruses; 2014 Nov; 6(11):4628-63. PubMed ID: 25421891
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
Lo Presti A; Cella E; Angeletti S; Ciccozzi M
Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
[TBL] [Abstract][Full Text] [Related]
12. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
13. Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia.
Lohachanakul J; Phuklia W; Thannagith M; Thongsakulprasert T; Smith DR; Ubol S
J Med Virol; 2015 May; 87(5):733-9. PubMed ID: 25656089
[TBL] [Abstract][Full Text] [Related]
14. Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis.
Phuklia W; Kasisith J; Modhiran N; Rodpai E; Thannagith M; Thongsakulprasert T; Smith DR; Ubol S
Virus Res; 2013 Nov; 177(2):179-88. PubMed ID: 24012515
[TBL] [Abstract][Full Text] [Related]
15. Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.
Hong JP; McCarthy MK; Davenport BJ; Morrison TE; Diamond MS
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578287
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
Issac TH; Tan EL; Chu JJ
J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
[TBL] [Abstract][Full Text] [Related]
17. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Persistence of Chikungunya Virus-Associated Manifestations and Anti-Chikungunya Virus Antibody in Southern Thailand: 5 Years After an Outbreak in 2008-2009.
Ninla-Aesong P; Mitarnun W; Noipha K
Viral Immunol; 2020 Mar; 33(2):86-93. PubMed ID: 31976828
[TBL] [Abstract][Full Text] [Related]
19. Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease.
Herrero LJ; Foo SS; Sheng KC; Chen W; Forwood MR; Bucala R; Mahalingam S
J Virol; 2015 Aug; 89(15):8063-76. PubMed ID: 26018160
[TBL] [Abstract][Full Text] [Related]
20. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
